相关实验视频

Updated: Jul 4, 2025

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

一个关于SelectMDx在前列腺癌诊断准确性的元分析

Hanting Wu¹, Yanling Wu², Peijie He¹

¹School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.

|February 8, 2024

概括

SelectMDx在检测临床上显著的前列腺癌方面表现出中等到良好的准确性. 需要进一步进行高质量的研究来确认其诊断性能,并了解变化因素.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
在瘤学瘤学.
诊断的准确性诊断的准确性

背景情况:

前列腺癌的诊断依赖于准确的方法来识别临床上重要的疾病.
SelectMDx是一种用于评估临床显著前列腺癌风险的生物标志物测试.

结论:

SelectMDx在临床上显著的前列腺癌的诊断准确度中等至良好.
研究之间存在异质性,特别是样本大小.
需要更高质量的临床研究来进一步验证SelectMDx的诊断效用.

更多相关视频

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

相关概念视频